Featured Research

from universities, journals, and other organizations

New type of cell communication regulates blood vessel formation, tumor growth

Date:
March 20, 2014
Source:
Uppsala University
Summary:
When tumours grow, new blood vessels are formed that deliver oxygen and nutrients to the tumour cells. A research group has discovered a new type of cell communication that results in suppressed blood vessel formation and delayed tumor growth. The results might explain why healthy individuals can have microscopic tumors for many years, which do not progress without formation of new blood vessels.

When tumors grow, new blood vessels are formed that deliver oxygen and nutrients to the tumor cells. A research group at Uppsala University has discovered a new type of cell communication that results in suppressed blood vessel formation and delayed tumor growth. The results might explain why healthy individuals can have microscopic tumors for many years, which do not progress without formation of new blood vessels.

Communication between cells controls their behaviour, e.g. survival, growth and mobility. In tumors, communication between tumor cells and blood vessel cells regulates the formation of new blood vessels that is required for tumors to grow.

One of the most important components controlling blood vessel formation is the growth factor VEGF. By binding to a receptor on the surface of blood vessel cells VEGF can induce signals that in turn regulate if new blood vessels should be formed or not.

In the present study, published in Developmental Cell, the researchers have studied how an additional molecule participates in the cell communication in response to VEGF. If this molecule, called NRP1, is present on the same cell as the VEGF-receptor a positive signal is delivered into the cell, leading to blood vessel growth. On the other hand, if NRP1 is present on another adjacent cell, e.g. a tumor cell, binding of VEGF will lock the receptor to the cell surface and it will loose its ability to send a positive signal into the cell.

- We call this kind of inhibited signalling trans communication and it suppresses the formation of new blood vessels. This results in delayed tumor growth. If trans communication occurs very early in tumor development tumor growth can be inhibited completely, says Lena Claesson-Welsh, professor at the Department of Immunology, Genetics and Pathology, who is responsible for the study.

Trans communication can also occur between cells of the same type. Therefore, in order for blood vessels to grow and form new vessels, trans communication between blood vessel cells must be avoided. This can be achieved if NRP1 levels vary between the cells. I accordance with this, the research group also found that fluctuating NRP1 levels occur naturally in adjacent cells in blood vessels in the eye.


Story Source:

The above story is based on materials provided by Uppsala University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Sina Koch, Laurens A. van Meeteren, Eric Morin, Chiara Testini, Simone Weström, Hanna Björkelund, Sébastien Le Jan, Jeremy Adler, Philipp Berger, Lena Claesson-Welsh. NRP1 Presented in trans to the Endothelium Arrests VEGFR2 Endocytosis, Preventing Angiogenic Signaling and Tumor Initiation. Developmental Cell, 2014; DOI: 10.1016/j.devcel.2014.02.010

Cite This Page:

Uppsala University. "New type of cell communication regulates blood vessel formation, tumor growth." ScienceDaily. ScienceDaily, 20 March 2014. <www.sciencedaily.com/releases/2014/03/140320121858.htm>.
Uppsala University. (2014, March 20). New type of cell communication regulates blood vessel formation, tumor growth. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140320121858.htm
Uppsala University. "New type of cell communication regulates blood vessel formation, tumor growth." ScienceDaily. www.sciencedaily.com/releases/2014/03/140320121858.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins